Project Details
Description
Long-term Follow-Up of Participants of the Phase II study to evaluate subcutaneous abatacept vs placebo in diffuse cutaneous systemic sclerosis - a double-blind, placebo-controlled, randomized trial
| Status | Active |
|---|---|
| Effective start/end date | 1/1/19 → 7/31/26 |
Funding
- UNIVERSITY OF MICHIGAN
- BRISTOL-MYERS SQUIBB COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.